Boehme SA et al. have demonstrated that MAP3K19 was also overexpressed in the alveolar macrophages of patients with idiopathic pulmonary fibrosis and in the alveolar macrophages, bronchial epithelia, and inflammatory cells of patients with COPD [3,4]. Here, MAP3K19 is linked to pulmonary fibrosis.